Abstract:Background: The mechanisms by which any upper respiratory virus, including SARS-CoV-2, impairs chemosensory function are not known. COVID-19 is frequently associated with olfactory dysfunction after viral infection, which provides a research opportunity to evaluate the natural course of this neurological finding. Clinical trials and prospective and histological studies of new-onset post-viral olfactory dysfunction have been limited by small sample sizes and a paucity of advanced neuroimaging data and neuropathological samples. Although data from neuropathological specimens are now available, neuroimaging of the olfactory system during the acute phase of infection is still rare due to infection control concerns and critical illness and represents a substantial gap in knowledge. Recent developments: The active replication of SARS-CoV-2 within the brain parenchyma (ie, in neurons and glia) has not been proven. Nevertheless, post-viral olfactory dysfunction can be viewed as a focal neurological deficit in patients with COVID-19. Evidence is also sparse for a direct causal relation between SARS-CoV-2 infection and abnormal brain findings at autopsy, and for trans-synaptic spread of the virus from the olfactory epithelium to the olfactory bulb. Taken together, clinical, radiological, histological, ultrastructural, and molecular data implicate inflammation, with or without infection, in either the olfactory epithelium, the olfactory bulb, or both. This inflammation leads to persistent olfactory deficits in a subset of people who have recovered from COVID-19. Neuroimaging has revealed localised inflammation in intracranial olfactory structures. To date, histopathological, ultrastructural, and molecular evidence does not suggest that SARS-CoV-2 is an obligate neuropathogen. WHERE NEXT?: The prevalence of CNS and olfactory bulb pathosis in patients with COVID-19 is not known. We postulate that, in people who have recovered from COVID-19, a chronic, recrudescent, or permanent olfactory deficit could be prognostic for an increased likelihood of neurological sequelae or neurodegenerative disorders in the long term. An inflammatory stimulus from the nasal olfactory epithelium to the olfactory bulbs and connected brain regions might accelerate pathological processes and symptomatic progression of neurodegenerative disease. Persistent olfactory impairment with or without perceptual distortions (ie, parosmias or phantosmias) after SARS-CoV-2 infection could, therefore, serve as a marker to identify people with an increased long-term risk of neurological disease.

Diagnosed and subjectively perceived long-term effects of COVID-19 infection on olfactory function assessed by supervised machine learning

Assessment of olfactory recovery after COVID-19: cross-sectional study

Factors Associated With Persisting Olfactory Dysfunction After COVID‐19

Recovery rates of persistent post-COVID-19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study

High prevalence of olfactory disorders 18 months after contracting COVID-19: a case-control study

Post-viral effects of COVID-19 in the olfactory system and their implications

Clinical Features of Olfactory Dysfunction in COVID-19 Patients

Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

Olfactory recovery following infection with COVID-19: A systematic review

Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review and meta-analysis

Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection

Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations

Olfactory dysfunction as an early predictor for post‐COVID condition at 1‐year follow‐up

Olfactory Training Impacts Olfactory Dysfunction Induced by COVID-19: A Pilot Study

Adherence to olfactory training improves orthonasal and retronasal olfaction in post-COVID-19 olfactory loss

Association between olfactory dysfunction and mood disturbances with objective and subjective cognitive deficits in long-COVID

Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19

Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19

Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19